+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Molecular Diagnostics Global Market Report 2022

  • PDF Icon

    Report

  • 175 Pages
  • September 2022
  • Region: Global
  • The Business Research Company
  • ID: 5656268
UP TO OFF until Dec 31st 2023

Quick Summary:

In today's fast-paced, health-centric environment, the global molecular diagnostics market has a pivotal role to play. This industry is a key player in the treatment of a wide variety of conditions, including congenital anomalies, infectious diseases and cancer. Noted for the provision of services and related products that guide patient management, molecular diagnostics provide a critical lens into the biological markers in an organism’s genetic code.

Major players in the field include Becton, BioMérieux SA., Danaher Corporation, Grifols, Hologic Inc., Novartis AG, QIAGEN, Siemens Healthcare GmbH, Abbott, and Dickinson and Company. These companies have expanded their range of offerings to include instruments, reagents, consumables, software and services. With applications in various areas including, but not limited to, oncology, pharmacogenomics, genetic testing and cardiovascular disease, the value of the molecular diagnostics market is undeniable. For insight into this rapidly evolving market, look no further than this comprehensive molecular diagnostics report.

The major players in the molecular diagnostics market are Becton, BioMérieux SA., Danaher Corporation, Grifols, Hologic Inc., Novartis AG, QIAGEN, Siemens Healthcare GmbH, Abbott, and Dickinson and Company.

The global molecular diagnostics market is expected to grow from $49.49 billion in 2021 to $49.64 billion in 2022 at a compound annual growth rate (CAGR) of 0.3%. The molecular diagnostics market is expected to decline to $47.78 billion in 2026 at a compound annual growth rate (CAGR) of -1.0%.

The molecular diagnostics market consists of sales of molecular diagnostics services and related products by entities (organizations, sole traders, partnership) that are utilised to direct patient management, from diagnosis to treatment, especially in the treatment of congenital anomalies, infectious diseases, and cancer. Molecular diagnostic is a term used to describe a class of techniques that are used to examine biological markers in the genetic code (genome) of an organism and to determine how their cells express their genes as proteins.

The main types of products of molecular diagnostics are instruments, reagents, consumables, software, and services. Instruments refer to a measuring device for determining the present value of a quantity under observation. The technologies include polymerase chain reaction (PCR), DNA sequencing, and next-generation sequencing and these are used in oncology, pharmacogenomics, infectious diseases, genetic testing, neurological disease, cardiovascular disease, microbiology, and other applications. The various end-users are hospitals, laboratories, and other end-users (blood banks, home health agencies, and nursing homes).

North America was the largest region in the molecular diagnostics market in 2021. The regions covered in molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The rising prevalence of infectious diseases and cancers of different forms drives the molecular diagnostics market. To determine whether mutations to a gene or chromosome may raise a person's chance of acquiring cancer or other disorders, molecular testing is employed. The increasing prevalence of infectious diseases and various types of cancer creates a demand for new diagnostic procedures including fast and specific molecular diagnostic tests. For instance, in 2020, according to National Cancer Institute, a US-based government agency, an estimated 1,806,590 new cases of cancer would be diagnosed in the United States and 606,520 people would die from the disease. Therefore, the increasing prevalence of cancer is driving the growth of the molecular diagnostic market.

The advances in genomics and proteomics are a key trend gaining popularity in the molecular diagnostics market. Polymerase chain reaction (PCR) is a recent development in genomics and helps in discovering new approaches to molecular diagnosis for disease diagnosis and pathogenesis of diseases. This enables better monitoring and a fast diagnosis and major organizations are investing to have a competitive edge. Following the trend, $600 million to support COVID-19 vaccine and therapy clinical trials led by the private sector, and for Canadian bio-manufacturing opportunities. This announcement was part of the $1 billion Plan to Mobilize Science. The growing research in proteomics and genomics will help develop more advanced molecular diagnostic techniques in the forecast period.

In April 2021, Hologic, a US-based women’s health technology company, acquired Mobidiag Oy for an undisclosed amount. The acquisition would accelerate the global growth of Mobidiag’s molecular diagnostic test platforms, which offer ease of use, multiplex capability, and rapid turnaround time. Mobidiag Oy is a Finland-based company that develops and provides molecular diagnostics for infectious diseases and antibiotic resistance.

The countries covered in the molecular diagnostics market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia."



This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary2. Molecular Diagnostics Market Characteristics
3. Molecular Diagnostics Market Size And Growth
3.1. Global Molecular Diagnostics Historic Market, 2016-2021, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Molecular Diagnostics Forecast Market, 2021-2026F, 2031F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Molecular Diagnostics Market Segmentation
4.1. Global Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Polymerase Chain Rreaction (PCR)
  • DNA Sequencing
  • Next-Generation Sequencing
4.2. Global Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Instruments
  • Reagents and Consumables
  • Software & Services
4.3. Global Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oncology
  • Pharmacogenomics
  • Infectious Diseases
  • Genetic Testing
  • Neurological Disease
  • Cardiovascular Disease
  • Microbiology
  • Others
4.4. Global Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals
  • Laboratories
  • Others (Blood Banks, Home Health Agencies, and Nursing Homes)
5. Molecular Diagnostics Market Regional And Country Analysis
5.1. Global Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
5.2. Global Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
6. Asia-Pacific Molecular Diagnostics Market
6.1. Asia-Pacific Molecular Diagnostics Market Overview
6.2. Asia-Pacific Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7. China Molecular Diagnostics Market
7.1. China Molecular Diagnostics Market Overview
7.2. China Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
8. India Molecular Diagnostics Market
8.1. India Molecular Diagnostics Market Overview
8.2. India Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. Japan Molecular Diagnostics Market
9.1. Japan Molecular Diagnostics Market Overview
9.2. Japan Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10. Australia Molecular Diagnostics Market
10.1. Australia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Indonesia Molecular Diagnostics Market
11.1. Indonesia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. South Korea Molecular Diagnostics Market
12.1. South Korea Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Western Europe Molecular Diagnostics Market
13.1. Western Europe Molecular Diagnostics Market Overview
13.2. Western Europe Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. UK Molecular Diagnostics Market
14.1. UK Molecular Diagnostics Market Overview
14.2. UK Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Germany Molecular Diagnostics Market
15.1. Germany Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. France Molecular Diagnostics Market
16.3. France Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Eastern Europe Molecular Diagnostics Market
17.1. Eastern Europe Molecular Diagnostics Market Overview
17.2. Eastern Europe Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. Russia Molecular Diagnostics Market
18.1. Russia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. North America Molecular Diagnostics Market
19.1. North America Molecular Diagnostics Market Overview
19.2. North America Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. USA Molecular Diagnostics Market
20.1. USA Molecular Diagnostics Market Overview
20.2. USA Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. South America Molecular Diagnostics Market
21.1. South America Molecular Diagnostics Market Overview
21.2. South America Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. Brazil Molecular Diagnostics Market
22.1. Brazil Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. Middle East Molecular Diagnostics Market
23.1. Middle East Molecular Diagnostics Market Overview
23.2. Middle East Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Africa Molecular Diagnostics Market
24.1. Africa Molecular Diagnostics Market Overview
24.2. Africa Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Molecular Diagnostics Market Competitive Landscape And Company Profiles
25.1. Molecular Diagnostics Market Competitive Landscape
25.2. Molecular Diagnostics Market Company Profiles
25.2.1. Becton
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. BioMérieux SA.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Danaher Corporation
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Grifols
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Hologic Inc.
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Molecular Diagnostics Market27. Molecular Diagnostics Market Trends And Strategies28. Molecular Diagnostics Market Future Outlook and Potential Analysis
29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer

Executive Summary

Molecular Diagnostics Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global Molecular Diagnostics market.

This report focuses on Molecular Diagnostics market which is experiencing strong growth. The report gives a guide to the Molecular Diagnostics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for the Molecular Diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Molecular Diagnostics global market report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Molecular Diagnostics market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The Molecular Diagnostics market section of the report gives context. It compares the Molecular Diagnostics market with other segments of the Molecular Diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, Molecular Diagnostics indicators comparison.

Scope

Markets Covered:

1) By Technology: Polymerase Chain Reaction (PCR), DNA Sequencing, Next-Generation Sequencing
2) By Product: Instruments, Reagents and Consumables, Software & Services
3) By Application: Oncology, Pharmacogenomics, Infectious Diseases, Genetic Testing, Neurological Disease, Cardiovascular Disease, Microbiology, Others
4) By End-User: Hospitals, Laboratories, Others (Blood Banks, Home Health Agencies, and Nursing Homes)

Companies Mentioned: Becton, BioMérieux SA., Danaher Corporation, Grifols, Hologic Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
"

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Becton
  • BioMérieux SA
  • Danaher Corporation
  • Grifols
  • Hologic Inc.
  • Novartis AG
  • QIAGEN
  • Siemens Healthcare GmbH
  • Abbott, Dickinson and Company
  • Hoffmann-La Roche Ltd.
  • BD
  • Bio-Rad Laboratories
  • Johnson & Johnson
  • Cepheid
  • Roche Diagnostics
  • Alere
  • Bayer AG
  • Dako
  • Sysmex Corporation
  • Agilent Technologies
  • Diasorin
  • Illumina
  • Thermo Fisher Scientific
  • Biocartis Group NV
  • Other Players

Methodology

Loading
LOADING...